Brensocatib

Adult Dosing .

Dosage forms:  TAB

Investigational New Drug (IND)

[pending FDA approval]

non-cystic fibrosis bronchiectasis

[indication/pt population pending FDA approval]

Info: inhibits dipeptidyl peptidase 1 (DPP-1), reducing neutrophil serine proteases activity

Peds Dosing .

Dosage forms:  TAB

Investigational New Drug (IND)

[pending FDA approval]

non-cystic fibrosis bronchiectasis

[indication/pt population pending FDA approval]

Info: inhibits dipeptidyl peptidase 1 (DPP-1), reducing neutrophil serine protease activity